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The incidence of melanoma has been
increasing in the last decades around 3% to
8% annually1-3. Australia is the country with
the highest incidence rates3. Over the years,
educational programmes have played an
important role in the early detection of
melanoma, although its treatment in
advanced stages is still limited. The mor-
tality has also increased, although in a
smaller scale. Melanoma is the 5th and 6th
cause of death in men and in women,
respectively1. The median age at diagnosis
is 45-55 years1.
The most related risk factors are: genetic
markers (mutation CDKN2a), family and
personal history of dysplastic naevi or
melanoma, presence of congenital naevi,
INTRODUCTION
Melanoma results from the malignant
transformation of melanocytes. Although
most melanomas are in the skin they can
also appear in other locations, such as the
eyes and mucous membranes (mouth, lar-
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ABSTRACT
The authors reviewed all cases of melanoma diagnosed in the Hospital Central of Funchal,
from January 1998 through December 2004. Fifty-one patients were studied, with ages
ranging from 20 to 85 years. Sixty-five per cent were female. The most common anatom-
ical location in females was the lower limbs (45%) and in males the trunk (44%). At the
time of diagnosis the majority of tumours were in stages I and II (57%). All patients were
submitted to conventional surgery.
Eighteen patients (35%) developed metastatic disease and 21 patients (41%) died (18 of
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atypical naevus syndrome, the number
(> 50) and size (> 5 mm) of melanocytic
naevi, skin type I/II and ultraviolet irradia-
tion - sunburns in childhood and intermit-
tent sun exposure1-3. However, melanoma
can arise in any age group and in individu-
als without history of substantial sun expo-
sure1.
Melanoma can be classified into four
main clinical subtypes: superficial spread-
ing (60%-70%), nodular (15%-30%),
lentigo maligna (5%-15%) and acral lentig-
inous (5%-10%)3. As in all neoplasms,
prognosis  depends on the stage at the time
of diagnosis. In surgically treated
melanomas with thickness ≤ 1 mm, the sur-
vival rate at the end of one year is superior
to 90%. For thicker tumours the survival
varies between 50% and 90%1. Because of
its aggressive behaviour and tendency to
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metastasise, prevention and early detection
are of major importance.
The present work is a review of all
melanoma cases diagnosed and treated in
our Hospital over a 7-year period (1998-
-2004). 
MATERIAL AND METHODS
We performed a retrospective analysis of all
patients with a histological diagnosis of
melanoma in the period between the 1st of
January 1998 and 31st of December 2004 (7
years), in our Hospital. 
The data was obtained from the clinical
records of the Departments of Dermatology,
General Surgery, Plastic Surgery and
Oncology. The studied clinico-pathological
parameters were: sex, age, anatomical loca-
tion, Breslow thickness, Clark's level, clin-
Fig.1 - Distribution of malignant melanoma cases per year.
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ical stage at diagnosis, clinical evolution
and follow-up.
RESULTS
Over the study period, a total of 51 cases of
melanoma were examined, with variable
distribution along the years, with a larger
number of cases in the year 2002 (Fig. 1).
Of the 51 patients, 33 (65%) were females
and 18 (35%) were males. The mean age
was, in both sexes, 61 years, with ages rang-
ing from 20 to 85 years (Fig. 2).
The most common anatomical locations
were the lower limbs (thigh, leg and foot) in
females, with 45% of cases (15 patients),
and the trunk in males, with 44% (8
patients) (Figs. 3 and 4). Four of our patients
had ocular melanoma. All tumours were pri-
mary and the clinical diagnoses were histo-
logically confirmed. 
Breslow thickness was ≤ 1.0mm in 6
cases , between 1.01 and 4,0 mm in 25 cases
and > 4.0 mm in 14 cases; this index could
not be assessed in 6 cases due to lack of data
(Fig. 5). Nineteen tumours (37%) were of
Clark level III and no data was available in
five cases (Fig. 6).
At the initial diagnosis, 57% of patients
were in stages I and II, 10% in stage III and
(25%) were in stage IV (Fig. 7).
All patients were treated by conventional
surgery.
One patient (male, with melanoma of the
right foot) died 13 days post-surgery from
cerebral and pulmonary metastases. The
follow-up on the remaining 50 patients
ranged between 1 and 8 years, with 30
patients staying disease free. Of the 21
patients who died, metastases developed in
18 cases (35%) and were located, from
decreasing order of frequency, in the
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Fig. 2 - Age and sex distribution of MM patients.
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Fig. 3 - Anatomical location in female MM patients.
Fig.4 - Anatomical location in male MM patients.
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Fig. 5 - Breslow thickness of tumours.
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Fig. 6 - Clark's level of tumours.
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inguinal lymphatic ganglia, lungs and brain,
liver, skin and mediastinum. Three (6%)
died from unrelated causes, namely
myocardial infarction, stroke and pneumo-
nia. Thus, the actual mortality rate related to
melanoma was 18 patients, corresponding
to 35% of the cases (Table I and Fig. 8). Of
the 18 patients who died from direct cause
of melanoma, 12 (67%) were in clinical
stage IV, at the time of diagnosis (Fig. 9).
The majority of these patients (78%) died 1-
-3 years after histological diagnosis.
CONCLUSION
During the study period (1998-2004), we
did not observe a gradual increase in the
number of new melanoma cases, unlike
what is reported in the literature2,3
We found a higher prevalence in females,
with a proportion of 65% females versus
35% males (1.9:1), which is in agreement
with the published data5,6.
The mean age at diagnosis, was 61 years,
in both sexes, which is slightly older than
that of other studies (45-55 years)1.
The location more frequently found in
women was the lower limbs and in men it
was the trunk, which is in agreement with
the literature. 
All our patients were submitted to con-
ventional surgery with safety margins, fol-
lowed, in some patients, by chemotherapy
and/or immunotherapy with interferon-α.
Breslow thickness, the main independent
prognostic indicator for melanoma, was > 4
mm in 14 cases, which reflects a worse sur-
vival. Clark level III applied to 19 cases. 
Fifty-seven per cent of our cases were in
clinical stages I and II, 10% in stage III and
a high percentage of cases in the stage IV
(25%). According to the 2007 Practice
Fig. 7 - Clinical stage of MM.
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Fig. 8 - Mortality of MM patients.
F = females; M = males
* Death not related with melanoma.
Malignant melanoma - A review 187
TABLE I
Follow-up of Melanoma Patients
No. of Metastases Deceased patients
Follow-up living F M F M
(years) patients 
< 1 44 5 6 2 5 (4+1*) 
1-3 35 6 0 7 (6+1*) 2
3-5 31 1 0 4 0
> 5 30 0 0 1 (0+1*) 0
Total 30 12 6 14 7
30 (59%) 18 (35%) 21 (41%)
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Guidelines in Oncology  and with base in
the American Joint Committee on Cancer
(AJCC) staging system for melanoma, it is
considered that 82%-85% of the patients
with melanoma have localized disease
(stages I or II), 10%-13% have regional dis-
ease (stage III) and 2%-5% have metastatic
disease (stage IV), at the moment of the
diagnosis.
In our patients, the mortality directly
attributable to the melanoma was of 35%;
most of these patients (78%) died 1-3 years
after histological diagnosis. 
Melanoma is an aggressive tumour and, in
a significant percentage of cases, the diag-
nosis is  made at a late stage of the disease,
accounting for a high mortality. It is impor-
tant to give continuity to the educational
campaigns through pamphlets, newspapers,
television, etc., that may lead to early and
effective detection. Early diagnosis and sur-
gical excision of melanoma are still the
main keys for the decrease of morbidity and
mortality of this tumour2,10.
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